University of Minnesota. Driven to Discover.
CMS will boost payments for the use of new antibiotics and for treating patients who have drug-resistant infections.
A list of critical-need antimicrobials would guide awards, which include incentives and responsibilities for companies, including stewardship reporting.
Since July 2012, the FDA has approved 12 products that are now on the market.
In response, the FDA said it has already made headway in fixing the problems and will take further steps in 2018.
Panel finds overall response was thorough, but notes policy gaps and some missteps after the samples were found.
The budget supports earlier commitment to Gavi vaccine initiatives but dials back funds for other global health efforts.
In other Zika developments, the CDC released new fact sheets for pregnant women about the complexities involved in Zika testing.
A mouse study shows that the virus replicates in vaginal tissue for several days, while CDC officials report increasing case numbers.
Inovio Pharmaceuticals will launch a phase 1 clinical trial of a DNA-based vaccine.
At times consumers were at risk "for several weeks after FDA was aware of a potentially hazardous food," the report says.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.